Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer
収録刊行物
-
- Cancer
-
Cancer 116 (10), 2401-2408, 2010
Cancer 116 (10), 2401-2408, 2010